Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06300944
Status:
RECRUITING
Last Update Posted:
2024-03-08
First Post:
2024-02-23
Brief Title:
The Effect of Esketamine on Postoperative Pain Relief in Patients Undergoing Laparoscopic Surgery
Sponsor:
General Hospital of Ningxia Medical University
Organization:
General Hospital of Ningxia Medical University
Study Overview
Official Title:
The Effect of Low-dose Ketamine on Postoperative Pain Relief and Sleep Quality in Patients Undergoing Laparoscopic Uterine Surgery
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate whether continuous intraoperative infusion of esketamine combined with the addition of esketamine to postoperative PCIA can improve postoperative pain and sleep quality in patients undergoing laparoscopic uterine surgery under general anesthesia
Detailed Description:
Esketamine is the right isomer of ketamine which is better than the original ketamine and has fewer side effects In addition for some gynecological hysterectomy patients who have poor sleep quality and anxiety after surgery Esketamine also has the effect of treating depression Due to the side effects of postoperative nausea vomiting and hyperalgesia caused by excessive dosage of some opioids this study will continue to inject small doses of esketamine during the operation to reduce the intraoperative dosage of opioids and add esketamine to the postoperative PCIA for analgesia To explore whether this method can reduce the incidence of moderate and severe postoperative pain in patients with laparoscopic uterine surgery under general anesthesia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None